What You Should Know:
- Reliant AI, a provider of generative AI-powered data analytics software, today announced its official launch and a significant $11.3M in seed funding round led by Tola Capital and Inovia Capital, with participation from angel investor Mike Volpi, the investment will fuel the company's growth and expansion.
- Founded by a team of leading experts in natural language processing and reinforcement learning with backgrounds at DeepMind, Google Brain, and EY
Read More
Digital Health | News, Analysis, Insights - HIT Consultant
West Tennessee Healthcare Expands AI Engagement with Xsolis
What You Should Know:
- Xsolis, the AI-driven health technology company fostering collaboration between healthcare providers and payers, today announced an expansion of its partnership with West Tennessee Healthcare, a healthcare system with seven hospitals serving West Tennessee, to streamline medical necessity case reviews and reduce length of stay.
- The collaboration between Xsolis and West Tennessee Healthcare has led West Tennessee Healthcare to $5.1 million in savings since the
Read More
Combat Health Misinformation with Conversational Intelligence
The digital era presents healthcare leaders with a formidable challenge: a tidal wave of online health misinformation shaping patient behaviors and decisions. A single viral social media post can ignite widespread confusion, driving patients to pursue treatments, medications, or services that may—or may not—relate to their condition or patient journey. Healthcare organizations then scramble to manage surging call volumes, strained resources, frustrated patients, and a compromised healthcare
Read More
Accenture Invests in Earli Inc. for Early Cancer Detection
What You Should Know:
- Accenture today announced a strategic investment in Earli Inc., a biotechnology company pioneering a novel approach to early cancer detection.
- Earli’s groundbreaking technology aims to transform cancer diagnosis and treatment by enabling the rapid and accurate identification of cancerous cells.
Synthetic Targeting Platform for Early Cancer Detection
Earli has developed a synthetic targeting platform that selectively reprograms cancer cells,
Read More
Caresyntax Secures $180M to Advance Precision Surgery Platform
What You Should Know:
- Caresyntax, a leader in vendor-neutral precision surgery platforms raises $180M in funding, comprised of $80M in equity and up to $100M in growth debt, will fuel the company's continued growth and development of its AI-powered surgical platform.
- The funding round was led by a consortium of prominent investors, including Symbiotic Capital, MTIP AG, BIONIQ Capital, and BlackRock Innovation Capital. This significant investment demonstrates the growing
Read More
From Comfort to Cure’: Answering the Call of ASCO 2024
The landscape of cancer treatment has continued to evolve, and the annual ASCO Meetings often set the stage for “what’s next in cancer care.” The overarching narrative at the 2024 ASCO Annual Meeting “From Comfort to Cure,” calls providers to view treatment plans with an emphasis on quality of life. To answer this call, we must implement solutions that enable providers to maintain the quality of life without compromising the quality of care.
Quality of life is personal
Providers
Read More
Photon Raises $9M to Expand Access to Text-Based Prescriptions
What You Should Know:
- Photon Health, a digital health startup focused on reimagining the prescription experience raises $9M in Series A funding round led by Notation and Flare Capital. The round also saw participation from existing investors and a group of notable angel investors.
- Photon has developed a platform that simplifies the prescription process for both patients and providers.
Patient Friendly Pharmacy Experdience
By digitizing prescriptions and providing
Read More
Paige Appoints Razik Yousfi as CEO to Drive AI Innovation in Pathology
What You Should Know:
- Paige, a leader in next-generation AI technology, announced the appointment of Razik Yousfi as Chief Technology Officer and Chief Executive Officer. Yousfi, who has been instrumental in Paige’s product development and technology strategy since 2019, will now lead the company’s efforts to advance AI in pathology and oncology.
- Under Yousfi’s leadership, Paige will intensify its focus on developing cutting-edge AI solutions to address critical challenges in
Read More
Authenticx Launches AI Models to Detect Reportable Events in Healthcare Conversations
What You Should Know:
- Authenticx, a leader in conversational intelligence for healthcare launches new suite of AI models capable of detecting reportable events within customer interactions.
- The new AI models empowers pharmacovigilance and patient safety teams to operate more efficiently and effectively.
Detecting Healthcare-Specific Compliance Events and Streamlining Reporting
The AI models can identify various reportable safety events, including adverse events,
Read More
HistoSonics Secures $102M to Advance Non-Invasive Liver Tumor Treatment
What You Should Know:
- HistoSonics, a medical technology company specializing in histotripsy, a non-invasive treatment for liver tumors raises $102M in Series D financing round.
- Led by Alpha Wave Ventures, with participation from new investors Amzak Health and HealthQuest Capital, and existing investors including Johnson & Johnson Innovation – JJDC, Inc., Venture Investors, Lumira Ventures, Yonjin Venture, and the State of Wisconsin Investment Board, the funding will
Read More
